We are monitoring the impact of COVID-19 & Recession alarm on MEA Antibodies Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Antibodies Market Research Report – Segmented By Product Type, Indication, End User, Application & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1117
Pages: 145

MEA Antibodies Market Size (2022 to 2027)

The size of the Middle East & Africa Antibodies Market was valued at 7.46 billion in 2022 and estimated to reach USD 9.68 billion by the end of 2027, with a growing potential of 5.36 % during the forecast period.

Antibodies (Ab’s) are proteins produced by Plasma cells (differentiated B-Cells) that helps the immune system to detect and neutralize pathogens such as Viruses and bacteria. Antibodies can be triggered and directed at microorganisms, foreign proteins, and toxins. These antibodies are used as diagnostics as well as Therapeutic purposes for several indications of diseases, including but not limited to rheumatoid arthritis, Crohn’s disease, macular degeneration, asthma, and hypercholesterolemia.

Some of the major factors that are influencing the Middle East and Africa Antibodies market are the rising rate of adoption to therapeutic antibodies in the cost-sensitive market, innovative products, growing chronic illnesses due to population shift and increasing longevity, quick approval for breakthrough therapies by regulatory authorities, and adoption of diagnostic antibodies. On the other hand, side effects associated with antibody treatment and increasing cost of treatment are the factors that hamper the market's growth.

This research report on the MEA antibodies market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Monoclonal Antibodies
    • Murine
    • Chimeric
    • Humanized
    • Human
  • Polyclonal Antibodies
    • Type I
    • Type II
    • Type III
    • Type IV
    • Type V
    • Type VI
    • Type VII
    • Type VIII
  • Anti-body drug complexes
    • Immunogen Technology
    • Seattle Genetics Technology
    • Immunomedics Technology

By Indication:

  • Cancer
  • Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • CNS Disorders
  • Others (Inflammatory, Microbial Diseases, & Other)

By End User:

  • Hospitals/Clinics
  • Research institute
  • Diagnostics laboratories

By Application:

  • Medical
  • Experimental
  • Western blot
  • ELISA
  • Radioimmune Assays
  • Immunofluorescence
  • Others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The MEA antibodies market is expected to register a moderate share in the global market during the forecast period due to the improving healthcare sector, supportive government incentives and investment for research & development activities, and advancing infrastructure. Increasing R&D Activities are uplifting the market growth, as the monoclonal antibody is used as a study or diagnostic tool by the researchers, who use various methodological techniques to improve antibody production. These antibodies can be used to evaluate immunoassays and create medical treatments. Immunoassay tests are used to see if a patient's blood or other fluid sample has a certain antigen or antibody. It's commonly used in the creation of new drugs, drug monitoring, and food sample testing.

In the Middle East and Africa, Saudi Arabia dominates the Antibodies market owing to the rising prevalence of cardiovascular illness, increase in the elderly population, and increased demand for antibodies for research reproductivity. In addition, surging government expenditures in reducing healthcare costs and enhanced development efforts to provide better diagnostic treatment are boosting the market.

The market in the United Arab Emirates is estimated to grow significantly in the coming years. The market growth is expected to be driven by ongoing technological advancements, improved accessibility, and rising disposable income will influence the industry's development in this region and the various strategic initiatives these industries undertake.

KEY MARKET PLAYERS:

Companies that play a prominent role in the MEA antibodies market profiled in the report are Abbott Diagnostics, Novartis AG, Pfizer Inc, ThermoFisher Scientific Inc, Eli Lilly, and company A.G. Scientific Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, and AbbVie Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies     

                                                5.1.1.1 Murine

                                                5.1.1.2 Chimeric

                                                5.1.1.3 Humanized

                                                5.1.1.4 Human 

                                5.1.2 Polyclonal Antibodies         

                                                5.1.2.1 Type I

                                                5.1.2.2 Type II

                                                5.1.2.3 Type III

                                                5.1.2.4 Type IV

                                                5.1.2.5 Type V

                                                5.1.2.6 Type VI

                                                5.1.2.7 Type VII

                                                5.1.2.8 Type VIII

                                5.1.3 Antibody-Drug Complexes

                                                5.1.3.1 Immunogen Technology

                                                5.1.3.2 Seattle Genetics Technology

                                                5.1.3.3 Immunomedics Technology

                5.2 By Indication                              

                                5.2.1 Cancer      

                                5.2.2 Autoimmune Diseases       

                                5.2.3 Infectious Diseases             

                                5.2.4 Cardiovascular Diseases    

                                5.2.5 CNS Disorders       

                                5.2.6 Others (Inflammatory, Microbial Diseases, & Other)             

                5.3 End User                     

                                5.3.1 Hospitals/Clinics   

                                5.3.2 Research Institute

                                5.3.3 Diagnostic Laboratories     

                5.4 Application                 

                                5.4.1 Medical    

                                5.4.2 Experimental         

                                                5.4.2.1 Western Blot

                                                5.4.2.2 ELISA

                                                5.4.2.3 Radioimmune Assays 

                                                5.4.2.4 Immunofluorescence 

                                                5.4.2.5 Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

6. Geographical Analysis                                              

                6.1 Middle East & Africa               

                                6.1.1 Introduction           

                                6.1.2 Middle-East            

                                6.1.3 Africa        

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

                7.5 Key Trends in Antibodies Development                         

                                7.5.1 Targeted Therapies             

                7.6 Promising Antibodies in Pipeline                       

                7.7 Heat Map of Safety and Efficacy for Pipeline and Marketed Antibodies                            

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Abbott Diagnostics (US)                        

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Novartis AG (Switzerland)                    

                9.3 Pfizer Inc. (U.S.)                       

                9.4 Thermo Fisher Scientific Inc. (U.S.)                   

                9.5 Eli Lilly and Company (U.S.)                 

                9.6 A.G. Scientific, Inc. (U.S.)                      

                9.7 Bristol-Myers Squibb (U.S.)                 

                9.9 F. Hoffmann-La Roche Ltd. (Switzerland)                       

                9.10 AbbVie Inc. (U.S.)                  

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Expert Opinions                                         

                11.1 Market Outlook                     

                11.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Monoclonal Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Polyclonal Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Antibody-Drug complexes Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Cancer Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Auto immune diseases Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa infectious diseases Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Cardiovascular diseases Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa CNS disorders Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Research institute Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Diagnostics laboratories Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Medical Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Experimental Market, By Region, From 2022 - 2027 (USD Million)
  18. Middle East Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  19. Middle East Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  20. Middle East Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  21. Middle East Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  22. Africa Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  23. Africa Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  24. Africa Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  25. Africa Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  26. Middle East & Africa Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  27. Middle East & Africa Murine Market, By Region, From 2022 - 2027 (USD Million)
  28. Middle East & Africa Chimeric Market, By Region, From 2022 - 2027 (USD Million)
  29. Middle East & Africa Humanized Market, By Region, From 2022 - 2027 (USD Million)
  30. Middle East & Africa Human Market, By Region, From 2022 - 2027 (USD Million)
  31. Middle East Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  32. Africa Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  33. Middle East & Africa Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  34. Middle East & Africa Type I Market, By Region, From 2022 - 2027 (USD Million)
  35. Middle East & Africa Type II Market, By Region, From 2022 - 2027 (USD Million)
  36. Middle East & Africa Type III Market, By Region, From 2022 - 2027 (USD Million)
  37. Middle East & Africa Type IV Market, By Region, From 2022 - 2027 (USD Million)
  38. Middle East & Africa Type V Market, By Region, From 2022 - 2027 (USD Million)
  39. Middle East & Africa Type VI Market, By Region, From 2022 - 2027 (USD Million)
  40. Middle East & Africa Type VII Market, By Region, From 2022 - 2027 (USD Million)
  41. Middle East & Africa Type VIII Market, By Region, From 2022 - 2027 (USD Million)
  42. Middle East Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  43. Africa Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  44. Middle East & Africa Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  45. Middle East & Africa Immunogen Technology Market, By Region, From 2022 - 2027 (USD Million)
  46. Middle East & Africa Seattle Genetics Technology Market, By Region, From 2022 - 2027 (USD Million)
  47. Middle East & Africa Immunomedics technology Market, By Region, From 2022 - 2027 (USD Million)
  48. Middle East Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  49. Africa Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  50. Middle East & Africa Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  51. Middle East & Africa Western Blot Market, By Region, From 2022 - 2027 (USD Million)
  52. Middle East & Africa ELISA Market, By Region, From 2022 - 2027 (USD Million)
  53. Middle East & Africa Radioimmune Assays Market, By Region, From 2022 - 2027 (USD Million)
  54. Middle East & Africa immunofluorescence Market, By Region, From 2022 - 2027 (USD Million)
  55. Middle East Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  56. Africa Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample